Two genetic mutations in liver cells may drive tumor formation in intrahepatic cholangiocarcinoma (iCCA), the second most common form of liver cancer, according to new research.
No considerable survival difference found between patients receiving everolimus and those receiving a placebo.
Lifestyle factors such as overeating, smoking, drinking too much and not enough exercises may be to blame for a sharp rise in liver and skin cancer cases.
What is currently known about stage IV well-differentiated liver cancer with no cirrhosis?
Antiviral treatment for hepatitis B virus (HBV) may be associated with a lower risk of hepatocellular carcinoma, researchers reported.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|